Mixed ionic electronic conductors: devices, systems and methods of use

Patent metadata

Field	Value
Publication number	US-11633587-B2
Application number	US-201916597792-A
Country	US
Kind code	B2
Filing date	Oct 9, 2019
Priority date	Apr 10, 2018
Publication date	Apr 25, 2023
Grant date	Apr 25, 2023

Abstract

The invention provides a variety of novel devices, systems, and methods of utilizing mixed-ionic-electronic conductor (MIEC) materials adapted to function with an applied current or potential. The materials, as part of a circuit, are placed in contact with a part of a human or nonhuman animal body. A sodium selective membrane system utilizing the MIEC is also described.

First claim

What is claimed:

1. A method of treating a human or nonhuman animal, comprising:
providing an apparatus comprising a MIEC disposed between an anode and cathode;
wherein the MIEC comprises an electrical conductor, ionic conductor, and elastomeric particles;
applying the MIEC directly in contact with skin of the human or nonhuman animal; and
passing an electrical current through the MIEC wherein at least 90 mass % of the elastomeric particles have diameters in a range of 50 nm to 10 μm.

2. The method of claim 1 , wherein the current heats the MIEC to a temperature in the range of 35 to 40° C.

3. The method of claim 1 , wherein the MIEC comprises a dispersed drug or therapeutic agent; and wherein the current passed through the MIEC increases the permeability of the skin.

4. The method of claim 1 , wherein the method does not utilize a hydrogel.

5. The method of claim 1 , wherein the MIEC is placed in direct contact with a wound in the skin.

6. The method of claim 1 , wherein the electrical conductor has an aspect ratio of at least 10× length compared to height and width.

7. The method of claim 1 , wherein the elastomeric particles comprise: nitrile butadiene rubber, natural rubber, silicone, Kraton-type, silicone acrylic, or polyurethane.

8. The method of claim 1 , wherein the electrical conductor is selected from the group consisting of carbon nanotubes, graphene and graphite structures, and metal nanowires.

9. The method of claim 1 , wherein the ionic conductor comprises sodium hyaluronate.

10. The method of claim 1 , wherein the ionic conductor comprises a mucoadhesive compound.

11. The method of claim 1 , wherein the MIEC has a conductivity in a range of 2000 mS/cm to 4000 mS/cm.

12. The method of claim 3 , wherein the dispersed drug or therapeutic agent comprises: hydrocortisone, lidocaine, salicylates, dexamethasone, sumatriptan, or a negatively charged protein.

13. The method of claim 3 , wherein the dispersed drug or therapeutic agent comprises: an anesthetic, fat removal compound, nutrient, nonsteroidal anti-inflammatory drug (NSAID), agent for the treatment of migraine, hair growth modulator, antifungal agent, anti-viral agent, vaccine component, tissue volume enhancing compound, anti-cellulite therapeutic, wound healing compound, compound useful to effect smoking cessation, agent for prevention of collagen shrinkage, wrinkle relief compound, compound for relief of bruising, cannabinoid, compound for adipolysis, compound for the treatment of hyperhidrosis, acne therapeutic, pigment for skin coloration for medical or cosmetic tattooing, sunscreen compound, hormone, insulin, corn/callous remover, wart remover, or combination thereof.

14. The method of claim 3 , wherein the dispersed drug or therapeutic agent is selected from the group consisting of: benzocaine, lidocaine, tetracaine, bupivacaine, cocaine, etidocaine, mepivacaine, pramoxine, prilocaine, procaine, chloroprocaine, oxyprocaine, proparacaine, ropivacaine, dyclonine, dibucaine, propoxycaine, chloroxylenol, cinchocaine, dexivacaine, diamocaine, hexylcaine, levobupivacaine, propoxycaine, pyrrocaine, risocaine, rodocaine, pharmaceutically acceptable derivatives thereof, bioisosteres thereof, and combinations thereof.

15. The method of claim 7 , wherein the MIEC comprises 10-50 wt % CNT, 20-50 wt % ionic conductor, and 5-70 wt % elastomer.

16. The method of claim 5 , wherein the MIEC composition is applied as a dispersion onto a wound where it hardens to form a form-fitting dressing on the wound.

17. The method of claim 5 , wherein the MIEC is formed by a method comprising electrospinning a mixture of CNTs and ionic conductors.

18. The method of claim 1 , wherein the ionic conductor has a molecular weight greater than 25,000 g/mol.

Assignees

• Battelle Memorial Institute

Inventors

• Heintz Amy M
• Shqau Krenar
• Lalgudi Ramanathan
• Palmer Katherine M

Classifications

• A61B5/259

  using conductive adhesive means, e.g. gels · CPC title

• C08J2309/04

  Latex · CPC title

• H01B1/04

  mainly consisting of carbon-silicon compounds, carbon or silicon · CPC title

• A61N1/0448 Primary

  Drug reservoir · CPC title

• A61B5/0006

  ECG or EEG signals · CPC title